BiosyncX · The Family Risk Audit
Hereditary cancer risk, assessed
BREAST One panel · every inherited line
1.0 m · THE SURFACE · FR 0001
The surface The tissue The bloodstream The cell The genome
biosyncX The Family Risk Audit

It runs in your family.
Does it run in you?

Scroll. Go beneath the history.

▼ Descend
01 · The tissue

Your family history is a story told by the people who lived long enough to tell it.

An aunt who died young of something nobody named properly. A quiet side of the family you have never spoken to. You built your sense of your own risk out of that.

02 · The bloodstream
51.7%

of the cancer and cardiovascular findings in one executive health cohort were in people whose family history gave no warning at all.

Mayo Clinic Proceedings, executive health genomics cohort. 35 of 301 carried an actionable variant.
03 · The cell

One draw. Read by a physician.

A germline panel, drawn from bloodHereditary cancer genes with established clinical guidance.
Physician interpretationRead against your own history, not a population average.
A written reportWhat it means, and what it does not mean.
A screening schedule built for your genomeWhich imaging, how often, starting when.
04 · The genome

Fixed at conception.
Personal to you.
Still unread.

Inherited risk sits outside every test you have already taken. It either passed to you, or it did not. This is where the answer lives.

The number you already live with

1 in 5 people will hear the word cancer about themselves.

You know this. You have watched it happen: an aunt, a colleague, a friend your own age. And each time, somewhere underneath the sympathy, the same private question. Am I carrying it too?

Five to ten percent of cancers run on an inherited variant. Written before birth. Carried for decades. Passed on at one in two: each child of a carrier flips the same coin. Your parents flipped it for you. You have flipped it for your children. No one in your family has ever read the result.

Lifetime risk: WHO / IARC. Hereditary fraction and inheritance: established clinical genetics.
Every year, worldwide

The lines a germline panel reads.

Breast2.3 millionnew cases a year · 1 in 8 women
Prostate1.5 millionnew cases a year · 1 in 8 men
Colorectal1.9 millionnew cases a year · rising in people under 50
Ovarian324,000new cases a year · often found late
Pancreatic511,000new cases a year · the quietest of them all
Stomach969,000new cases a year

Behind a share of every one of those numbers is a family that could have seen it coming. A known variant does more than explain the past. It rewrites the screening schedule for everyone who carries it, years before anything exists to find.

Global incidence: GLOBOCAN 2022, IARC. Lifetime risks: SEER / American Cancer Society.
The gap

You have been tested for everything except what you were born with.

Your executive medical measures what is happening now. Your pressure this morning. Your cholesterol this quarter. Inherited risk sits outside that window entirely: fixed at conception, personal to you, and in most people who have had every other test, still unread. The proxy you use instead, family history, can be wrong in both directions. Cancer through three generations and nothing in you. A quiet family and a variant that should change how you are screened for the rest of your life.

Declining the test does not change the answer. It only keeps the answer from you. The variant is either there or it is not. The one thing you choose is whether you find out while it is still just information.

The Family Risk Audit reads it. For you, and for the man or woman beside you. Your children inherit from both sides.

What it costs
The Family Risk AuditPanel, physician interpretation, written report, screening plan.
USD 1,200
October founding cohortThe founding rate exists because this is a new service and the first cohort helps establish it.
USD 800
For twoBoth panels, individual results, one joint session for the family plan. Your children inherit from both sides.
USD 1,500
For someone you loveYou pay. They book their own consultation and decide for themselves. Nothing arrives at their door.
Gift
The consultation is free. You pay only if you decide to proceed after sitting with the physician.
Before anything is drawn

You sit with a physician first.

What the panel can find, what it cannot, and what a result would mean for you and for the people you share DNA with. You consent with all of that in front of you.

If something is found, a finding is the beginning of a plan: earlier imaging, tighter intervals, specialist referral where it is indicated, and a conversation about who else in your family should be tested. Your sister. Your daughter. Your son. One answer can protect an entire line.

And a clean result carries weight of its own. It ends a question your family has been quietly asking for a generation.

Your result is yours. Where a company sponsors the assessment, the company receives no individual result at any point.

Dr. Michael Taylor

Physician of record · BiosyncX Medical Ltd, Trinidad and Tobago

Every panel is ordered, interpreted and signed by the physician who sits with you. Nothing in your report is issued by software alone.

Physician-ledCLIA / CAP laboratoryGuideline-anchored
The October cohort

The question is already written in you.
Choose to read it.

Forty-five minutes with the physician who will read your panel. The consultation is free, and you pay only if you decide to proceed. You risk nothing by sitting down. The only risk is never asking.

Book the consultation

Availability is limited by physician hours rather than by lab capacity.